External study 6 Mar 2015

The economic footprint of the pharmaceutical industry

Read more
Infographic 6 Mar 2015

Improving prevention of women’s cancers in Latin America and The Caribbean

Read more
Infographic 6 Mar 2015

1) Did you know? Improving prevention of women’s cancers in Latin America and The Caribbean

Read more
Infographic 6 Mar 2015

2) Did you know? Improving prevention of women’s cancers in Latin America and The Caribbean

Read more
Infographic 6 Mar 2015

3) Did you know? Improving prevention of women’s cancers in Latin America and The Caribbean

Read more
Press release 5 Mar 2015

Open letter to G7 Heads of State on neglected tropical diseases

To: Chancellor Angela Merkel, Federal Republic of Germany, President of the 2015 G7 Prime Minister Shinzō Abe, Japan Prime Minister David Cameron, United Kingdom Prime Minister Stephen Harper, Canada President François Hollande, Republic of France President Barack Obama, United States of America Prime Minister Matteo Renzi, Republic of Italy Cc: G7 Foreign Ministers and G7...

Read more
Video 5 Mar 2015

Pharma R&D and global health – IFPMA facts & figures 2014

A ‘pharma by numbers’ video illustrating the key facts & figures that range from innovation in R&D to access to medicines and global health, and from the economic footprint to public private partnerships. This video is based on the IFPMA yearly flagship publication ‘The Pharmaceutical Industry & Global Health – Facts & Figures 2014’

Read more
Video 4 Mar 2015

Special IFPMA-DIA Announcement: 4th African Regulatory Conference 2015

A conference you should not miss: Caroline Mendy, IFPMA Regulatory Policy Manager, invites those interested in access to medicines and regulatory issues in and for Africa to join the IFPMA and Drug Information Association, in Dakar, 26 — 29 April 2015. Have your say on ‘Moving towards Regulatory Harmonisation to enhance Access to Medicines in...

Read more
Expert insight 4 Mar 2015

Four Priorities for Regulatory Convergence in Asia

What can be done to speed up access to new medicines for patients and improve quality, safety, and efficacy of medicines in Asia The 2015 Asia Regulatory Conference (ARC) on February 4-5 in Chinese Taipei brought together over 250 stakeholders from regulatory, pharmaceutical, academic, civil society, international and non-governmental organisations, including policy experts from Asia....

Read more
Video 23 Feb 2015

IFPMA 2015 interview series ‘Why taking flu shot should be your business’

Dr Abraham M. Palache, Influenza Scientist, Consultant at Abbott Biologicals and IFPMA Influenza Vaccine Supply International Task Force, talks about the importance of taking the flu shot. It is all about breaking misconceptions spread by anti-vaxxers. People most at risk should be given priority in receiving the flu shot. Find out who those most at...

Read more
Press release 19 Feb 2015

Pharmaceutical industry makes progress in cutting-edge R&D for neglected diseases

  Report shows 13% annual increase of pharmaceutical R&D projects to develop treatments to eliminate and control neglected diseases. In 2014, 186 projects were underway. 38 vaccines and treatments currently undergo clinical trials, 10 of which are in final stages. Projects include potential treatments and vaccines for TB, sleeping sickness, malaria, dengue, Chagas, schistosomiasis, intestinal...

Read more
Position paper 18 Feb 2015

IFPMA Position on Voluntary Licenses and Non-Assert Declarations

Read more